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utcome of Extracorporeal
embrane Oxygenation
or Early Primary Graft
ailure After Pediatric
eart Transplantation*
arl Lewis Backer, MD
hicago, Illinois
n this issue of the Journal, Tissot et al. (1) from the
hildren’s Hospital of Denver have presented the outcome
f patients undergoing extracorporeal membrane oxygen-
tion (ECMO) for early primary graft failure after pediatric
eart transplantation. Nine percent of their patient popula-
ion undergoing transplantation required post-operative
CMO support. Survival in this group was 54%. The
ong-term graft function of the patients supported with
CMO was similar to the overall transplant population.
See page 730
here are few situations more daunting for a pediatric heart
ransplant team than the patient who has difficulty being
eaned from cardiopulmonary bypass after an apparently
echnically successful heart transplantation. One of the great
oys of being a heart transplant surgeon is seeing the donor
eart in normal sinus rhythm with excellent ventricular
unction by transesophageal echocardiography and an easy
ean from cardiopulmonary bypass, chest closure, and a
riumphant return to the intensive care unit of a previously
ery sick patient. Conversely, the donor heart that does not
ant to function, has arrhythmias, and clearly is not going
o be weaned from cardiopulmonary bypass tends to deflate
he operating room of its enthusiasm.
This series of patients undergoing post-operative ECMO
herapy with a survival of 50%, and perhaps as important,
100% 3-year survival in the surviving patients gives hope
o surgical teams that are unable to wean a patient from
ardiopulmonary bypass after a heart transplantation. The
arkers predictive of ECMO survival and the experience of
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or thea
merican College of Cardiology.
From the Children’s Memorial Hospital, Chicago, Illinois.his transplant group with 300 patients undergoing trans-
lantation is a very good educational experience for any
enter in which pediatric heart transplantation is performed.
took away a number of points from this article and would
ike to highlight them in this editorial.
The total ischemic time of the donor heart has always
een considered important for graft function and survival of
he recipient. The total ischemic time in this series was
ignificantly longer for ECMO-rescued recipients com-
ared with the overall transplant population (276  86 min
s. 204  70 min, p  0.01). This 30-min time difference,
ssentially 4 h vs. 4.5 h, appears to be critically important.
his reminds all of us (i.e., the transplant procurement
urgeon, the coordinators, and the flight team) that vigi-
ance in the speed and efficiency of the procurement
ontinues to be important. All possible anticipated delays
hould be addressed and focused to make the procurement
s expeditious as possible. It is also an area that continues to
wait research that will improve donor preservation.
Hyperacute rejection was rare, with only 1 patient having
his indication for ECMO support. The fact that only 1 of
8 children had hyperacute rejection, and presumably this is
ctually 1 of 310 total children transplanted, would indicate
o me that in the current era of immunosuppression regi-
ens this has become a very rare event. Because the
utcome of hyperacute rejection is usually quite poor, the
act that it rarely happened is notable. In particular, the
ocus of the team when a donor heart is not able to support
he recipient patient should probably be less on the risk or
ossibility of hyperacute rejection and more on other fac-
ors, including long donor ischemia time and possible donor
ssues before the harvest such as long “downtime,” high-
ose pre-harvest inotropic support, and pre-operative anoxic
nsult to the heart (drowning, asphyxia, and so on).
The authors attempted to capture the characteristics of
CMO-rescued recipients. This step is important in that it
elps the surgeon and transplant team to possibly prepare
hemselves for the child who may require post-operative
CMO support. The first risk factor was the longer total
schemia time, which I discussed previously. The next risk
actor was younger age at the time of transplant, 1.3 years vs.
.8 years (p  0.002). This younger age goes along with the
ther factor, which is low weight at transplantation, 7.8 kg
s. 12.6 kg (p  0.0001). The smaller, younger patients
ppear to be at greater risk of requiring ECMO support.
hat has certainly been the experience at our center. Factors
hat were not important for ECMO-rescued recipients
ncluded indications for transplantation (i.e., cardiomyopa-
hy vs. congenital heart disease), the waiting time on the list
81 days vs. 77 days), and the donor-recipient weight ratio
1.9 vs. 1.8).
The authors evaluated patients who had neurological
omplications. These complications were found in 4 of 15
urvivors. Two had permanent neurological impairment,
nd 2 had transient and resolved seizures. Of interest, all of
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August 18, 2009:738–9 Extracorporeal Membrane Oxygenationhe patients with neurologic disability were emergently
annulated in the cardiac intensive care unit, and 3 of these
atients had cardiac arrest before cannulation. These out-
omes give some credence to the thought that, with a 54%
verall survival of patients on ECMO, earlier ECMO
ntervention rather than later ECMO intervention for the
orderline patients may be important. Some centers are
uite firm about not using high-dose inotropic support in
hese patients and go to early mechanical support, which
ill hopefully be a transient 24- to 48-h time of support.
learly, the patient who has a cardiac arrest in the imme-
iate perioperative period after heart transplantation is at
reater risk of neurologic complications as noted by these
uthors.
One conclusion that the authors note but I am not sure
hether I agree with is the time course of patients who are
n ECMO support. In their series no survivor required
CMO support for 4 days. They note in the discussion
hat recovery of ventricular function with 8 days of ECMO
upport has been reported and may become more common
s ECMO support technology progresses and improves over
ime. However, on the basis of their institutional experience,
hey recommend consideration be given to listing for
etransplantation or transition to a ventricular assist device if
he patient is not decannulated within 4 days of initiation of
CMO support. In our recent experience at our institution
uring the last 2 years we have had 3 children on post-
perative ECMO support, all of whom were on ECMO
upport for over a week and all of whom are currently alive
ith their initial graft in place.
As the authors suggest, given the challenges of shortage
f donors and the increased risk of transplantation after
echanical assistance, the decision to list for retransplanta-
ion should be reserved for those patients who are deemed to
e good candidates for this option. Given our own personal
xperience I believe that, particularly for patients where the
eft ventricular function is preserved but it is a right
entricular issue with borderline pulmonary artery pressures
nd pulmonary vascular resistance issues, the use of ECMO
or more than 4 days can still result in a successful outcome.
The results of this Denver series of ECMO requirement
n 9% of the patients and an overall survival rate of 54% are
ot dissimilar from a recent abstract presented at the
nternational Society of Heart and Lung Transplantation in
aris, France in April of 2009 (2). Dr. Groemmer and
olleagues from Vienna, Austria reported that between the
ears 2000 and 2008, 59 (14%) of 425 patients required
K
tCMO support after cardiac transplantation. The results of
his series were that 75% of the patients could be weaned
rom ECMO, and in-hospital survival of these patients was
5%, which is nearly identical to the Denver experience.
he duration of ECMO support was 5  4 days. The
urvival has actually improved, and there appears to be an
ra effect, with the survival being only 20% between the
ears 2000 and 2003 and 50% in the years 2004 to 2008.
he authors of this abstract concluded that ECMO is a
aluable tool to overcome primary graft dysfunction after
ardiac transplantation. It is interesting that the require-
ent for ECMO of 14% is very similar to the 9% in the
enver series and that the in-hospital survival of 55% was
lso nearly identical.
The paper by Tissot et al. (1) on the outcome of
xtracorporeal membrane oxygenation for early primary
raft failure for pediatric heart transplantation describes a
ery interesting experience and one that should be of great
nterest to all centers performing pediatric heart transplants.
he 54% survival rate in an extraordinarily complex group
f patients is quite good, but remains a number that needs to
e improved. In particular, the fact that all 15 children
uccessfully weaned off ECMO were discharged alive and had
100% 3-year survival is very encouraging. This series reminds
s that the total ischemic time continues to be important and
hat hyperacute rejection is rarely a cause of primary graft
ailure in the immediate peritransplant time period. As me-
hanical support technology improves and progresses over time
ne would anticipate that the results of post-operative ECMO
upport would continue to improve. The other support mech-
nism that may be important in the future is mechanical
entricular assist devices, which continue to be miniaturized
nd improved and add to our post-transplant armamentarium.
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